Population
Patients with cardiovascular disease
Design
Guideline
Authors
Loading...
Past guideline noncompliance warrants caution with legacy recommendations; reinforces need for rigorous development standards in current ESC documents.
This document provides expert consensus on the use of angiotensin converting enzyme inhibitors in cardiovascular disease from the European Society of Cardiology.
López‐Sendón et al. (2004) conducted a review in Cardiovascular disease. Angiotensin converting enzyme inhibitors was evaluated. Surveys of guidelines and expert consensus documents published between 1985 and 1998 demonstrated that methodological standards were not complied with in the vast majority of cases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: